According to a recent LinkedIn post from Nabla, the company participated in NextGen Healthcare’s FY27 Commercial Kickoff, which emphasized the themes of focus, speed, and impact. The post highlights discussions on evolving electronic health records from systems of record to systems of context, supported by artificial intelligence.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post notes that Nabla’s Chief Clinical Product Officer, Dr. Matthew Sakumoto, moderated a physician panel on “Live Telemetry: AI in Action,” featuring customer use cases of ambient AI that reportedly reduce after-hours work and help clinicians reconnect with patients. These examples suggest that Nabla is positioning its technology as a workflow and burnout-mitigation tool in clinical environments.
The post also indicates that Chief Product Officer Laurent Landowski participated in a session on NextGen’s Clinical AI roadmap and commercial growth. This involvement may signal deeper commercial alignment with NextGen and potential integration opportunities, which could expand Nabla’s addressable market if collaborations translate into scalable deployments.
More broadly, the event’s focus on speed and meaningful impact at scale suggests that clinical AI adoption is becoming a higher priority among EHR vendors and their clients. For investors, Nabla’s visibility alongside NextGen’s product leadership may imply strengthening ecosystem relationships and could be a positive indicator for future partnership-driven growth, though no specific financial details or contracts are mentioned in the post.